PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
22490409-7	2012	RESULTS: (1) Azithromycin pretreatment significantly inhibited both the release of three neutrophil-mobilizing cytokines (MIP-2, CXCL-5 and GM-CSF) and the accumulation of neutrophils in airways caused by mIL-17 stimulation.	Azithromycin	13-25	colony stimulating factor 2 (granulocyte-macrophage)	Mus musculus	140-146	
8158029-5	1994	Therefore, a significant reduction in the number of viable bacteria was observed in blood, liver, and spleen of mice treated with a combination of GM-CSF and azithromycin or amikacin compared with control mice and those treated with GM-CSF or antimicrobials alone.	Azithromycin	158-170	colony stimulating factor 2 (granulocyte-macrophage)	Mus musculus	233-239	
19633061-0	2009	Azithromycin and clarithromycin inhibit lipopolysaccharide-induced murine pulmonary neutrophilia mainly through effects on macrophage-derived granulocyte-macrophage colony-stimulating factor and interleukin-1beta.	Azithromycin	0-12	colony stimulating factor 2 (granulocyte-macrophage)	Mus musculus	142-190